Pivot Pharmaceuticals (OTCQB: PVOTF) is an emerging biotechnology company engaged in the development of novel therapeutics to treat unmet medical needs in women’s health, according to the company’s website (see here: www.PivotPharma.com). SNNLive spoke with Pravin R. Chaturvedi, Ph.D., President and CEO of Pivot Pharmaceuticals, Inc. at the SeeThruEquity 5th Annual MicroCap Investor Conference in New York City, NY.
In this video interview, Dr. Chaturvedi and our host discuss the following topics:
- Overview of Pivot Pharmaceuticals, Inc.
- Target indications
- Dr. Chaturvedi’s background
- Where the science comes from
- Discusses the company’s science
- Clinical Development
- Listing on the OTCQB
- Why the company developing therapeutics for women’s health
- Milestones for 2016-2017
For more information about Pivot Pharmaceuticals, Inc., please visit: www.PivotPharma.com
The interview may contain forward-looking statements about Pivot Pharmaceuticals, Inc. See Pivot Pharmaceuticals' periodic filings with the Securities and Exchange Commission for more complete information.
© 2017 Stock News Now
Supported by Superior Web Solutions